Childrens Memorial Hospital
Chicago, Illinois, 60614, United States
NCT Number: NCT01409785
The goal of this study is to compare the LMA Unique and LMA Supreme in children having surgery. We hypothesize that the airway leak pressures with the LMA Supreme will be superior to the LMA Unique. Airway leak pressures will be measured by recording the circuit pressure at which equilibrium is reached. The ease of placement, fiberoptic grade of laryngeal view, feasibility of use, and complications (airway related, gastric insufflation, trauma) will also be assessed.
Looking for future studies?
Notify Me6 month–6 year
All sexes
Observational
Chicago, Illinois, 60614, United States
The LMA Supreme is a newer version of the current model, the laryngeal mask airway Unique. Both models are approved for use by the FDA, and are routinely used for airway management during general anesthesia. Three main features distinguish the laryngeal mask airway Supreme from the original LMA: i) a curved rigid airway tube, ii) provision for a gastric drain tube, and iii) a larger mask for improved fit and airway seal.
The aim of this randomized prospective study is to compare two types of the laryngeal mask airway: the laryngeal mask airway Unique and the laryngeal mask airway Supreme, in pediatric patients without the use of neuromuscular blockade. Based on the design features listed above, we hypothesize that the airway leak pressures with the LMA Supreme will be superior to the LMA Unique. Airway leak pressures will be measured by recording the circuit pressure at which equilibrium is reached. The ease of placement, fiberoptic grade of laryngeal view, feasibility of use, and complications (airway related, gastric insufflation, trauma) will also be assessed.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
ASA class IV, V Emergency procedures
Time frame: after placement of the supraglottic airway device/ Participants will be followed 24 hours postoperatively
Airway leak pressures will be measured by recording the circuit pressure at which equilibrium is reached when fresh gas flow is delivered at 3L/min when the pressure limiting valve is closed completely.
Time frame: After placement of the supraglottic device
The laryngeal alignment through the devices will be graded using an established scoring system
Time frame: Participants will be followed 24 hours postoperatively
complications such as oxygen desaturations, mucosal trauma, reflex activation of the airway, sore throat, dysphonia will be recorded
Time frame: after placement of the supraglottic airway device
From picking up the airway device to bilateral chest expansion and presence of ETCO2
Time frame: at the beginning of anesthesia
number of attempts needed for successful placement will be recorde (maximum of 3 attempts will be considered as a failure)
Time frame: After placement of the LMA supreme
The view through the gastric drain tube of the LMA supreme will be assessed and graded using an established scoring system
Time frame: After placement of the LMA supreme
The ease of gastric placement will be assessed using a subjective scale
Time frame: During leak pressure testing
The presence of gastric insufflations will be assessed during leak pressure testing by using epigastric auscultation
Time frame: During maintenance of anesthesia
The quality of hands free anesthesia will be assessed during maintenance of anesthesia using a previously described scale
Ann & Robert H Lurie Children's Hospital of Chicago
Other
A Prospective, Randomized Comparison of the LMA Unique and LMA Supreme in Children
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01031407
Adult, Asperger Syndrome
Bethesda, Maryland, United States
View Trial DetailsNCT07728305
Children, Football-Specific Performance
Guarne, Antioquia, Colombia
View Trial DetailsNCT05915026
Children, Contrast Enhancement in Magnetic Resonance Imaging
Indian Wells, California, United States
View Trial DetailsNCT06988969
Behavior, Children
Yalova, Turkey (Türkiye)
View Trial Details